MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression
Authors:
- Agustí TollATAgustí Toll
- Rocío SalgadoRSRocío Salgado
- Blanca EspinetBEBlanca Espinet
- Angel Díaz-LagaresADAngel Díaz-Lagares
- Eugenia Hernández-RuizEHEugenia Hernández-Ruiz
- Evelyn AndradesEAEvelyn Andrades
- Juan SandovalJSJuan Sandoval
- Manel EstellerMEManel Esteller
- Ramón M PujolRPRamón M Pujol
- Inmaculada Hernández-MuñozIHInmaculada Hernández-Muñoz
Open Access
- 25 July 2016
- journal article
- research article
- Published by Springer Nature in Molecular Cancer
- Vol. 15 (1) , 1-15
Abstract
Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer and frequently progresses from an actinic keratosis (AK), a sun-induced keratinocyte intraepithelial neoplasia (KIN). Epigenetic mechanisms involved in the phenomenon of progression from AK to cSCC remain to be elicited. Expression of microRNAs in sun-exposed skin, AK and cSCC was analysed by Agilent microarrays. DNA methylation of miR-204 promoter was determined by bisulphite treatment and pyrosequencing. Identification of miR-204 targets and pathways was accomplished in HaCat cells. Immunofluorescence and immunohistochemistry were used to analyze STAT3 activation and PTPN11 expression in human biopsies. cSCCs display a marked downregulation of miR-204 expression when compared to AK. DNA methylation of miR-204 promoter was identified as one of the repressive mechanisms that accounts for miR-204 silencing in cSCC. In HaCaT cells miR-204 inhibits STAT3 and favours the MAPK signaling pathway, likely acting through PTPN11, a nuclear tyrosine phosphatase that is a direct miR-204 target. In non-peritumoral AK lesions, activated STAT3, as detected by pY705-STAT3 immunofluorescence, is retained in the membrane and cytoplasm compartments, whereas AK lesions adjacent to cSCCs display activated STAT3 in the nuclei. Our data suggest that miR-204 may act as a “rheostat” that controls the signalling towards the MAPK pathway or the STAT3 pathway in the progression from AK to cSCC.Keywords
Funding Information
- Instituto de Salud Carlos III (grants PI041728, PI10/00785, FIS PI11/02070, RD09/0076/00036, RD06/0020/0040, and PS09/00973)
This publication has 80 references indexed in Scilit:
- MicroRNA-31 Is Overexpressed in Cutaneous Squamous Cell Carcinoma and Regulates Cell Motility and Colony Formation Ability of Tumor CellsPLOS ONE, 2014
- MicroRNA in non-melanoma skin cancerCancer Biomarkers, 2012
- Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERKJournal of Molecular Medicine, 2012
- Progression From Atypical/Dysplastic Intraepidermal Proliferations and Carcinoma In Situ to Invasive Tumors: A Pathway Based on Current KnowledgeThe American Journal of Dermatopathology, 2011
- Sorafenib inhibits signal transducer and activator of transcription‐3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2†Hepatology, 2009
- Impact of normalization on miRNA microarray expression profilingRNA, 2009
- The emerging role of miR-200 family of MicroRNAs in epithelial-mesenchymal transition and cancer metastasisRNA Biology, 2008
- Discovery of a Novel Shp2 Protein Tyrosine Phosphatase InhibitorMolecular Pharmacology, 2006
- Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin CarcinogenesisCancer Research, 2004
- Genetic change in actinic keratoses.1996